Clinical trial • Phase IV • Immunology
Clinical trial in Acute graft-versus-host disease (grade III/IV) of liver and/or gastrointestinal tract
Phase IV trial for Acute graft-versus-host disease (grade III/IV) of liver and/or gastrointestinal tract. 23 participants.
Overview
- Trial Therapeutic Area
- Immunology
- Trial Disease
- Acute graft-versus-host disease (grade III/IV) of liver and/or gastrointestinal tract
- Trial Stage
- Phase IV
Key dates
- Initial CTIS Submission Date
- 14-10-2024
- First CTIS Authorization Date
- 11-02-2025
Trial design
Phase IV trial across 1 site in Netherlands.
- Target Sample Size
- 23
Recruitment
- Planned Sample Size
- 23
- Recruitment Window Months
- 24
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 23
Netherlands
- Earliest CTIS Part Ii Submission Date
- 31-01-2025
- Latest Decision Or Authorization Date
- 11-02-2025
- Processing Time Days
- 11
- Number Of Sites
- 1
- Number Of Participants
- 23
Sites
- Site Name
- Universitair Medisch Centrum Groningen
- Department Name
- Hematology
- Contact Person Name
- Emanuele Ammatuna
- Contact Person Email
- e.ammatuna@umcg.nl
Sponsor
Primary sponsor
- Full Name
- Universitair Medisch Centrum Groningen
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- Netherlands
Related trials
Other published trials that may interest you.
- BELIMUMAB for Antibody-mediated rejection (kidney transplant)|High HLA sensitization (transplant candidates)
- Belimumab for Systemic lupus erythematosus
- INEBILIZUMAB for Myasthenia gravis
- PREDNISONE for Granulomatosis with polyangiitis (Wegener's) | Microscopic polyangiitis | ANCA-associated vasculitis
- BIRCH POLLEN ALLERGOID GLUTARALDEHYDE MODIFIED for Allergic rhinitis due to birch pollen | Allergic rhinoconjunctivitis